- Report
- March 2025
- 84 Pages
Global
From €3500EUR$4,184USD£3,103GBP
- Report
- March 2025
- 86 Pages
Global
From €3500EUR$4,184USD£3,103GBP
- Report
- May 2025
- 138 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- May 2025
- 140 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- August 2025
- 89 Pages
Global
From €3500EUR$4,184USD£3,103GBP
- Report
- March 2025
- 93 Pages
Global
From €3500EUR$4,184USD£3,103GBP
- Report
- March 2025
- 110 Pages
Global
From €3500EUR$4,184USD£3,103GBP
- Report
- January 2025
- 93 Pages
Global
From €3500EUR$4,184USD£3,103GBP
- Report
- March 2026
- 234 Pages
Germany
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 235 Pages
India
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 233 Pages
Canada
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2026
- 242 Pages
China
From €4346EUR$4,850USD£3,722GBP
- Report
- February 2026
- 183 Pages
Canada
From €4346EUR$4,850USD£3,722GBP
- Report
- February 2026
- 192 Pages
China
From €4346EUR$4,850USD£3,722GBP
- Report
- February 2026
- 185 Pages
India
From €4346EUR$4,850USD£3,722GBP
- Report
- July 2025
- 150 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- July 2025
- 150 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- April 2025
- 150 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2025
- 150 Pages
Global
From €4346EUR$4,850USD£3,722GBP
- Report
- March 2025
- 150 Pages
Global
From €4346EUR$4,850USD£3,722GBP

Retinopathy is a medical condition that affects the retina, the light-sensitive tissue at the back of the eye. It is a leading cause of blindness and visual impairment worldwide. Optical treatments for retinopathy include laser photocoagulation, intravitreal injections, and vitrectomy. Laser photocoagulation is used to reduce the risk of vision loss by sealing off leaking blood vessels in the retina. Intravitreal injections are used to deliver medications directly to the retina to reduce swelling and inflammation. Vitrectomy is a surgical procedure used to remove scar tissue and other debris from the vitreous cavity.
Companies in the retinopathy market include Alcon, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Heidelberg Engineering, Nidek, Optos, Topcon, and Zeiss. Show Less Read more